查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球真皮填充剂市场（按性别、按材料、按最终用户、按分销管道、按主要地区）：行业趋势和预测（2023-2035）
市场调查报告书
商品编码
1411404

全球真皮填充剂市场（按性别、按材料、按最终用户、按分销管道、按主要地区）：行业趋势和预测（2023-2035）

Dermal Fillers Market, 2023-2035 - Distribution by Gender, by Material, End User, Distribution Channel and Key Geographical Regions : Industry Trends and Global Forecasts
出版日期: | 出版商: Roots Analysis | 英文 234 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

到 2023 年，全球真皮填充剂市场价值将达到 30 亿美元，在预测期内（2023-2035 年）复合年增长率为 9%。

在瞬息万变的医美世界中，跟上最新趋势已成为开发商和消费者的首要任务。 真皮填充剂，也称为脸部填充剂，是一种可注射的治疗方法，含有凝胶状物质形式的透明质酸。 皮肤填充剂最近已成为消费者最追捧的脸部年轻化、即时脸部提升、疤痕治疗和唇部增强的选择之一。 根据 IAPS 的数据，2022 年全球进行了超过 430 万例透明质酸真皮填充手术。 这主要是因为该手术是微创的，适合许多寻求整容手术的患者。 在某些情况下，这些手术可能是非侵入性的（很少或没有疼痛）。

真皮填充剂一般由玻尿酸、乳酸、羟基磷灰石钙和聚甲基丙烯酸甲酯凝胶製成。 真皮填充剂通常皮下注射到脸部区域，例如法令纹（法令纹）、木偶纹、脸颊和口腔连合处。 治疗不需要麻醉。 治疗持续时间从 5 个月到 5 年不等，具体取决于所使用的材料。 科学家们正在透过使用插管技术彻底改变真皮填充剂市场。 插管技术减少了手术的侵入性，最大限度地减少了瘀伤，并允许精确放置填充物。 技术进步也促进了下一代填料的开发。 这些填料具有更好的交联性能并提供更持久的效果。 由于对真皮填充剂治疗的需求不断增长以及每年需要真皮填充剂治疗的患者数量不断增加，因此预计真皮填充剂注射市场将在预测期内增长。

本报告分析了全球真皮填充剂市场，提供了产品概述、市场基本结构和最新情况、主要市场推动和限制因素、整体市场规模趋势展望、细分市场和我们调查按地区（共5个地区）的详细趋势、近期主要业务联盟及资本交易动向（投资、併购等）、当前竞争状况、主要公司概况等。

主要细分市场

依性别

  • 男性
  • 女性

依材质

  • 玻尿酸填充剂
  • 非玻尿酸填充剂

按最终使用者

  • 医院
  • 诊所/医疗水疗中心、皮肤科/美容中心
  • 其他最终用户

依销售管道

  • 直接销售
  • 间接销售

依主要地区划分

  • 北美洲（美国、加拿大、墨西哥）
  • 欧洲（英国、德国、法国、义大利、西班牙等）
  • 亚太地区（中国、韩国、日本、印度）
  • 中东/北非（土耳其、伊朗等）
  • 拉丁美洲（巴西、阿根廷等）

主要市场参与者

  • Allergan Aesthetics
  • Alma Lasers
  • Biotechitalia
  • Bison Medical
  • Koru Pharma
  • MedicalZone
  • Merz Pharma
  • Mesoestetic
  • MesoTech
  • NeoGenesis
  • Sinclair Pharma
  • Xcelene

目录

第一章简介

第二章研究方法

第 3 章经济趋势和其他特定于项目的考量

第 4 章执行摘要

第 5 章简介

  • 医美理念
  • 医学美学的演变
  • 真皮填充剂
  • 真皮填充剂的优点
  • 真皮填充剂的副作用
  • 医美主要促进生长因素
  • 最新医疗美容技术
  • 医学美容的主要挑战
  • 未来前景

第六章市场状况

  • 真皮填充剂：市场状况

第七章公司简介

  • 艾尔建美学
  • 克罗马製药
  • 高德玛
  • IBSA
  • 辛克莱製药

第八章企业竞争力分析

  • 主要假设和参数
  • 调查方法
  • 医学美学：企业竞争力分析

第 9 章伙伴关係与协作

  • 合作伙伴模式
  • 真皮填充剂：伙伴关係与协作
  • 按地区分析

第十章融资与投资

  • 融资模式
  • 真皮填充剂：融资与投资
  • 结论

第十一章市场影响分析：促进因素、限制因素、机会与挑战

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
  • 结论

第十二章全球真皮填充剂市场

  • 主要假设与研究方法
  • 全球真皮填充剂市场：过去趋势（2018-2022）与未来预测（2023-2035）
  • 主要细分市场
  • 动态仪表板

第 13 章皮肤填充剂市场，依最终用户划分

  • 主要假设与研究方法
  • 真皮填充剂市场：依最终使用者划分（2018 年、2023 年、2035 年）
  • 数据测量与验证

第 14 章真皮填充剂市场：依性别

  • 主要假设与研究方法
  • 真皮填充剂市场：依性别分类（2018、2023、2035）
  • 数据测量与验证

第 15 章皮肤填充剂市场，依通路划分

  • 主要假设与研究方法
  • 真皮填充剂市场，依通路划分（2018 年、2023 年、2035 年）
  • 数据测量与验证

第十六章真皮填充剂市场：依主要地区划分

  • 主要假设与研究方法
  • 真皮填充剂市场：依主要地区划分（2018 年、2023 年、2035 年）
  • 数据测量与验证

第十七章真皮填充剂产品市场

  • 主要假设与研究方法
  • 全球真皮填充剂产品市场：过去趋势（2018-2022）与未来预测（2023-2035）
  • 依主要地区划分的真皮填充剂产品市场（2018 年、2023 年、2035 年）
  • 数据测量与验证

第 18 章管理见解

第十九章结论

第 20 章附录 1：表格资料

第 21 章附录 2：公司与组织名单

简介目录
Product Code: RA100471

The dermal fillers market is valued at USD 3 billion in 2023 growing at a CAGR of 9% during the forecast period 2023-2035.

In the ever-changing world of medical aesthetics, staying up to date with the latest trends has become a priority for both the developers and the consumers. Dermal fillers are injectable treatments that contain hyaluronic acids in the form of gel-like substances. They are also called facial fillers. In recent years, dermal fillers have become one of the most sought-after options among consumers when it comes to facial rejuvenation, instant facial lift, scar treatment, and lip enhancement. According to IAPS, in 2022, more than 4.3 million Hyaluronic acid Dermal Filler procedures were performed worldwide. This is largely due to the fact that the procedure is minimally invasive, making it suitable for a large number of patients seeking cosmetic procedures. In some cases, these procedures can be non-invasive, meaning they involve minimal or no pain.

Dermal fillers are generally made up of hyaluronic acids, lactic acids, calcium hydroxyapatite and polymethyl methacrylic acid gels. Dermal fillers are usually injected under the skin in the following areas of the face: nasolabial fold, marionette line, cheeks, oral commissures, etc. Treatment does not require anesthesia. The duration of the treatment can range from 5 months up to 5 years depending on the material used. Scientists are revolutionizing the field of Dermal Fillers market by using cannula technique. Cannula technique involves the use of a blunt tip cannula despite the presence of a needle for the injection of fillers. This approach reduces the invasive nature of the procedure, minimizes bruising, and allows for precise placement of fillers. Technological advances have also enabled the development of next generation fillers. These fillers have better cross-linking characteristics and provide longer lasting results. With the growing demand and increasing number of patients requiring dermal filler treatments every year, the dermal filler injection market is expected to grow over the forecast period.

Key Market Segments

Gender

  • Male
  • Female

Material

  • Hyaluronic Fillers
  • Non-Hyaluronic Acid Fillers

End User

  • Hospitals
  • Clincs / Med Spas and Dermatology / Cosmetology Centers
  • Other end users

Distribution Channel

  • Direct Distribution
  • Indirect Distribution

Key Geographical Regions

  • North America (U.S., Canada, Mexico)
  • Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, South Korea, Japan, India)
  • Middle East and North Africa (Turkey, Iran, Rest of the Middle East and North Africa)
  • Latin America (Brazil, Argentina, Rest of the Latin America)

Research Coverage:

The report studies the dermal fillers market based on gender, material, end user, distribution channel, and key geographical regions

The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.

The report forecasts the revenue of market segments with respect to five major regions

The report provides an overview of medical aesthetics, including dermal fillers, benefits and drawbacks of these procedures. Further, the chapter also covers the new technologies applied in this field.

Comprehensive analysis of the current landscape of dermal filler developers considering parameters such as establishment year, company size, headquarters, application area and end user

In-depth profiles of companies offering dermal filler procedures products and / or devices, focusing on company overviews, financial information (where available), offered dermal filler procedures, recent advancements, and informed future prospects.

Detailed company competitiveness evaluation of dermal filler company, considering various parameters.

An analysis of partnerships established in this sector since 2018, covering merger and acquisition, distribution, commercialization, licensing, supply, product development, product and technology integration and manufacturing agreements.

A comprehensive examination of funding and investments made in medical aesthetics dermal fillers companies since 2018, encompassing venture capital financing, secondary offerings, private placements, grants, debt financing, and other equity.

The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.

Key Benefits of Buying this Report

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the dermal fillers market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies

  • Allergan Aesthetics
  • Alma Lasers
  • Biotechitalia
  • Bison Medical
  • Koru Pharma
  • MedicalZone
  • Merz Pharma
  • Mesoestetic
  • MesoTech
  • NeoGenesis
  • Sinclair Pharma
  • Xcelene

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Project Objectives
  • 1.3. Scope of the Report
  • 1.4. Inclusions and Exclusions
  • 1.5. Key Questions Answered
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Project Methodology
  • 2.4. Forecast Methodology
  • 2.5. Robust Quality Control
  • 2.6. Key Market Segmentations
  • 2.7. Key Considerations
    • 2.7.1. Demographics
    • 2.7.2. Economic Factors
    • 2.7.3. Government Regulations
    • 2.7.4. Supply Chain
    • 2.7.5. COVID Impact / Related Factors
    • 2.7.6. Market Access
    • 2.7.7. Healthcare Policies
    • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 3.1. Chapter Overview
  • 3.2. Market Dynamics
    • 3.2.1. Time Period
      • 3.2.1.1. Historical Trends
      • 3.2.1.2. Current and Forecasted Estimates
    • 3.2.2. Currency Coverage
      • 3.2.2.1. Overview of Major Currencies Affecting the Market
      • 3.2.2.2. Impact of Currency Fluctuations on the Industry
    • 3.2.3. Foreign Exchange Impact
      • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
      • 3.2.3.2. Strategies for Mitigating Foreign Exchange Ris
    • 3.2.4. Recession
      • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 3.2.5. Inflation
      • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

  • 5.1. Chapter Overview
  • 5.2. Concept of Medical Aesthetics
  • 5.3. Evolution of Medical Aesthetics
  • 5.4. Dermal Fillers
  • 5.5. Advantages of Dermal Fillers
  • 5.6. Side Effects of Dermal Fillers
  • 5.7. Key Growth Drivers of Medical Aesthetics
  • 5.8. Emerging Technologies in Medical Aesthetics
    • 5.8.1. Virtual Reality in Medical Aesthetics
    • 5.8.2. Augmented Reality in Medical Aesthetics
    • 5.8.3. Artificial Intelligence in Medical Aesthetics
    • 5.8.4. Telemedicine in Medical Aesthetics
  • 5.9. Key Challenges of Medical Aesthetics
  • 5.10. Future Perspectives

6. MARKET LANDSCAPE

  • 6.1. Chapter Overview
  • 6.2. Dermal Fillers: Overall Market Landscape
    • 6.2.1. Analysis by Year of Establishment
    • 6.2.2. Analysis by Company Size
    • 6.2.3. Analysis by Location of Headquarters (Region)
    • 6.2.4. Analysis by Location of Headquarters (Country)
    • 6.2.5. Analysis by Year of Establishment and Location of Headquarters (Region)
    • 6.2.6. Analysis by Company Size and Location of Headquarters (Region)
    • 6.2.7. Analysis by Application Area
    • 6.2.8. Analysis by End-user

7. COMPANY PROFILES

  • 7.1. Chapter Overview
  • 7.2. Allergan Aesthetics
    • 7.2.1. Company Overview
    • 7.2.2. Financial Information
    • 7.2.3. Medical Aesthetics Portfolio
    • 7.2.4. Recent Developments and Future Outlook
  • 7.3. Croma Pharma
    • 7.3.1. Company Overview
    • 7.3.2. Financial Information
    • 7.3.3. Medical Aesthetics Portfolio
    • 7.3.4. Recent Developments and Future Outlook
  • 7.4. Galderma
    • 7.4.1. Company Overview
    • 7.4.2. Financial Information
    • 7.4.3. Medical Aesthetics Portfolio
    • 7.4.4. Recent Developments and Future Outlook
  • 7.5. IBSA
    • 7.5.1. Company Overview
    • 7.5.2. Medical Aesthetics Portfolio
    • 7.5.3. Recent Developments and Future Outlook
  • 7.6. Sinclair Pharma
    • 7.6.1. Company Overview
    • 7.6.2. Medical Aesthetics Portfolio
    • 7.6.3. Recent Developments and Future Outlook

8. COMPANY COMPETITIVENESS ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Key Assumptions and Parameters
  • 8.3. Methodology
  • 8.4. Medical Aesthetics: Company Competitiveness Analysis
    • 8.4.1. Companies based in North America
    • 8.4.2. Companies based in Europe
    • 8.4.3 Companies based in Asia-Pacific and Rest of the World

9. PARTNERSHIPS AND COLLABORATIONS

  • 9.1. Chapter Overview
  • 9.2. Partnership Models
  • 9.3. Dermal Fillers: Partnerships and Collaborations
    • 9.3.1. Analysis by Year of Partnership
    • 9.3.2. Analysis by Type of Partnership
    • 9.3.3. Analysis by Year and Type of Partnership
    • 9.3.4. Analysis by Focus Area
    • 9.3.5. Most Active Players: Analysis by Number of Partnerships
  • 9.4. Analysis by Geography
    • 9.4.1. Local and International Agreements
    • 9.4.2. Intracontinental and Intercontinental Agreements

10. FUNDING AND INVESTMENTS

  • 10.1. Chapter Overview
  • 10.2. Funding Models
  • 10.3. Dermal Fillers: Funding and Investments
    • 10.3.1. Analysis by Year of Funding
    • 10.3.2. Analysis by Amount Invested
    • 10.3.3. Analysis by Type of Funding
    • 10.3.4. Analysis by Year and Type of Funding
    • 10.3.5. Analysis by Type of Funding and Amount Invested
    • 10.3.6. Analysis by Geography
    • 10.3.7. Most Active Players
      • 10.3.7.1. Analysis by Number of Funding Instances
      • 10.3.7.2. Analysis by Amount Raised
    • 10.3.9. Analysis by Company Size and Amount Invested
    • 10.3.10. Leading Investors: Analysis by Number of Funding Instances
  • 10.4. Concluding Remarks

11. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 11.1. Chapter Overview
  • 11.2. Market Drivers
  • 11.3. Market Restraints
  • 11.4. Market Opportunities
  • 11.5. Market Challenges
  • 11.6. Conclusion

12. GLOBAL DERMAL FILLERS MARKET

  • 12.1. Chapter Overview
  • 12.2. Key Assumptions and Methodology
  • 12.3. Global Dermal Fillers Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 12.3.1. Scenario Analysis
      • 12.3.1.1. Conservative Scenario Analysis
      • 12.3.1.2. Optimistic Scenario Analysis
  • 12.4. Key Market Segmentations
  • 12.5. Dynamic Dashboards

13. DERMAL FILLERS MARKET, BY END-USER

  • 13.1. Chapter Overview
  • 13.2. Key Assumptions and Methodology
  • 13.3. Dermal Fillers Market: Distribution by End-user, 2018, 2023 and 2035
    • 13.3.1. Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

13.3.2.. Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

    • 13.3.3. Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 13.4. Data Triangulation and Validation

14. DERMAL FILLERS MARKET, BY GENDER

  • 14.1. Chapter Overview
  • 14.2. Key Assumptions and Methodology
  • 14.3. Dermal Fillers Market: Distribution by Gender, 2018, 2023 and 2035
    • 14.3.1. Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.2. Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 14.4. Data Triangulation and Validation

15. DERMAL FILLERS MARKET, BY DISTRIBUTION CHANNEL

  • 15.1. Chapter Overview
  • 15.2. Key Assumptions and Methodology
  • 15.3. Dermal Fillers Market, by Distribution Channel, 2015, 2023 and 2035
    • 15.3.1. Direct Distribution: Historical Trends (2015-2022) and Forecasted Estimates (2023-2035)
    • 15.3.2. Indirect Distribution: Historical Trends (2015-2022) and Forecasted Estimates (2023-2035)
  • 15.4. Data Triangulation and Validation

16. DERMAL FILLERS MARKET, BY KEY GEOGRAPHICAL REGION

  • 16.1. Chapter Overview
  • 16.2. Key Assumptions and Methodology
  • 16.3. Dermal Fillers Market: Distribution by Key Geographical Regions, 2016, 2023 and 2035
    • 16.3.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.1.1. US: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.1.2. Canada: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.1.3. Mexico: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.1. UK: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.2. Germany: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.3. France: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.4. Italy: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.5. Spain: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.5. Rest of the Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.1. China: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.2. South Korea Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.3. Japan: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.4. India: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.4.1. Turkey: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.4.2. Iran: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.4.3. Rest of the Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.5.1. Brazil: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.5.2. Argentina: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.5.3. Rest of the Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 16.4. Data Triangulation and Validation

17. DERMAL FILLERS PRODUCT MARKET

  • 17.1. Chapter Overview
  • 17.2. Key Assumptions and Methodology
  • 17.3. Global Dermal Fillers Product Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.4. Dermal Fillers Products Market, by Key Geographical Regions, 2018, 2023 and 2035
    • 17.4.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.5. Data Triangulation and Validation

18. EXECUTIVE INSIGHTS

19. CONCLUSION

20. APPENDIX 1: TABULATED DATA

21. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS